Not a feature of tumor lysis syndrome-

Okay, let's tackle this question about tumor lysis syndrome. The question is asking which of the options is not a feature of tumor lysis syndrome. First, I need to recall what tumor lysis syndrome (TLS) is. TLS is a metabolic complication that occurs when a large number of cancer cells are destroyed rapidly, leading to the release of intracellular contents into the bloodstream. This typically happens after the initiation of chemotherapy, especially in tumors with high proliferative rates like lymphomas or leukemias.

The main features of TLS include hyperkalemia, hyperphosphatemia, hyperuricemia, and hypocalcemia. These are due to the breakdown of cells releasing potassium, phosphate, and nucleic acids. The uric acid comes from the breakdown of nucleic acids. Hyperphosphatemia can lead to precipitation of calcium phosphate in tissues, causing hypocalcemia. So, the key electrolyte disturbances are high potassium, high phosphate, high uric acid, and low calcium.

Now, looking at the options provided (though they're missing in the user's question), the correct answer is the one that doesn't fit these features. Let's assume the options are something like hyperkalemia, hypophosphatemia, hyperuricemia, and hypocalcemia. The incorrect feature would be hypophosphatemia because TLS is associated with hyperphosphatemia, not hypophosphatemia. So the answer would be the option stating hypophosphatemia.

But wait, the user hasn't provided the actual options. Hmm. Without the specific options, I need to make an educated guess. Let me think of common distractors. For example, if one of the options is hypercalcemia, that's not a feature of TLS. Or maybe hypokalemia. Alternatively, hyperphosphatemia is a key feature, so hypophosphatemia would be incorrect. Another possible incorrect option could be hypernatremia, which isn't part of TLS. But the most classic incorrect answer is hypophosphatemia because TLS leads to high phosphate levels.

So, the core concept here is the metabolic abnormalities in TLS. The correct answer would be the option that contradicts these known features. The explanation should detail why each correct feature is present and why the incorrect one isn't. For instance, hyperphosphatemia occurs due to cell lysis releasing phosphate, so hypophosphatemia is incorrect. The clinical pearl would be to remember the "4 Hs and a L" in TLS: hyperkalemia, hyperphosphatemia, hyperuricemia, hypocalcemia.

**Core Concept**
Tumor lysis syndrome (TLS) is a metabolic emergency caused by rapid tumor cell lysis, releasing intracellular contents into the bloodstream. Key features include **hyperkalemia**, **hyperphosphatemia**, **hyperuricemia**, and **hypocalcemia** due to phosphate-calcium precipitation.

**Why the Correct Answer is Right**
TLS arises from massive tumor cell death (e.g., after chemotherapy in high-grade lymphomas/leukemias), leading to intracellular potassium, phosphate, and nucleic acid release. Phosphate binds extracellular calcium, causing hypocalcemia. Uric acid (from nucleic acid breakdown) and potassium further exacerbate metabolic derangements. **Hyp

✓ Correct Answer: C. Hypercalcemia